Search

Your search keyword '"Federspiel, Birgitte"' showing total 351 results

Search Constraints

Start Over You searched for: Author "Federspiel, Birgitte" Remove constraint Author: "Federspiel, Birgitte"
351 results on '"Federspiel, Birgitte"'

Search Results

7. Pancreatic Islet Cell Tumors

9. Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine Tumors

13. 18F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy:a prospective 10-year follow-up study of 166 patients

14. Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

15. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

16. Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

17. Incidence, clinical presentation and trends in indication for diagnostic work-up of small intestinal and pancreatic neuroendocrine tumors

18. Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasms

19. Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

20. Long-term survival and recurrence after resection of bronchopulmonary carcinoids:A single-center cohort study of 236 patients

22. Neuroendocrine neoplasms of the appendix:Characterization of 335 patients referred to the Copenhagen NET Center of Excellence

23. PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

24. Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

26. Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms

27. Acinar cystic transformation of the pancreas:Report of a case and a review of the literature

28. Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors

29. PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

33. Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors

34. 18F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study

35. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

39. 64Cu-DOTATATE somatostatin receptor imaging in neuroendocrine tumors:experience from 500 patients at Copenhagen ENETS Center of Excellence

40. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma

41. Solid pseudopapillary neoplasm of the pancreas:Clinical-pathological features and management, a single-center experience

42. Isolated tumor cells in regional lymph nodes in patients with adenocarcinoma of the esophagogastric junction might represent part of true metastases

43. Impact of isolated tumor cells in regional lymph nodes in adeno-and squamous cell carcinoma of the esophagus and the esophagogastric junction:A systematic review

44. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer

46. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma

49. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer

50. Somatostatin analogue treatment primarily induce miRNA expression changes and up-regulates growth inhibitory miR-7 and miR-148a in neuroendocrine cells

Catalog

Books, media, physical & digital resources